C12N 2710/10071
Demonstrated in vivo effect
C12N2710/10071 (Demonstrated in vivo effect) appears on 41 US grants and 82 published applications in this corpus.
Search patents in C12N- Granted patents
- 41
- Published applications
- 82
- Assignees
- 57
- Inventors
- 156
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 3 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 0 | 2 |
| 2014 | 2 | 1 |
| 2015 | 2 | 13 |
| 2016 | 3 | 7 |
| 2017 | 2 | 5 |
| 2018 | 5 | 6 |
| 2019 | 4 | 7 |
| 2020 | 3 | 5 |
| 2021 | 4 | 2 |
| 2022 | 6 | 6 |
| 2023 | 1 | 6 |
| 2024 | 3 | 6 |
| 2025 | 5 | 3 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Combination immunotherapy15 Sep 2026US 12,735,466 B2The Regents of the University of California
- Recombinant adeno-associated virus capsids with enhanced human pancreatic tropism11 Nov 2025US 12,467,065 B2The Board of Trustees of the Leland Stanford Junior University
- Dosing regime and formulations for type B adenoviruses8 Jul 2025US 12,350,302 B2Akamis Bio Limited
- Adenovirus library and methods8 Jul 2025US 12,351,797 B2Regents of the University of Minnesota
- Therapeutic pharmaceutical composition for bone and soft tissue tumors27 May 2025US 12,310,998 B2Surv BioPharma Inc.
- Materials and methods for increasing immune responses within a mammal8 Oct 2026US 2026/0306668 A1Mayo Foundation for Medical Education and Research
- Dosing regime and formulations for type b adenoviruses30 Jul 2026US 2026/0216263 A1Akamis Bio Limited
- Pharmaceutical composition for resisting infection with sars-cov-2 or mutant thereof, and combined drug thereof12 Feb 2026US 2026/0041761 A1Westvac Biopharma Co., Ltd.
- Virus encoding transgenes to complement cellular therapy28 Aug 2025US 2025/0269012 A1Akamis Bio Limited
- Viral delivery of neoantigens28 Aug 2025US 2025/0270589 A1Seattle Project Corp.
Most cited
By later US patents
- Adenovirus library and methods3US 10,208,304 B2Regents of the University of Minnesota · 2019
- Compositions and methods for inducing migration by dendritic cells and an immune response3US 8,932,575 B2University of Miami · 2015
- Adenoviral-based biological delivery and expression system for use in the treatment of osteoarthritis2US 10,301,647 B2Baylor College of Medicine · 2019
- Materials and methods for the treatment of pathological neovascularization in the eye2US 8,785,413 B2Florida Atlantic University Research Corporation · 2014
- Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases2US 9,388,414 B2Trustees of Dartmouth College · 2016